Descrease article font size Increase article font size Canada’s health regulator has approved Novo Nordisk’s weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction …
New Delhi: Semaglutide, a fat-busting weekly injectable that has been a global smash hit since its launch five years ago, may soon have a successor that promises to be even …
Promising trials of a new antibiotic drug trademarked as Zaynich – meant to act against all major superbugs – has triggered a sharp run-up in the Wockhardt stock. It has …
The makers of Ozempic say their weight-loss drug Wegovy will be available to patients in Canada starting Monday. Novo Nordisk’s weekly injection is approved for weight loss among patients diagnosed with obesity. …
Descrease article font size Increase article font size Canadians will be able to get their hands on Wegovy, a weight-loss drug from Ozempic-maker Novo Nordisk, in spring 2024, the company …
Ozempic maker Novo Nordisk is facing a proposed class action lawsuit that alleges the company has not properly warned Canadians about severe side effects, including stomach paralysis and gallbladder disease. …
Home Business Weight-loss Injection Wegovy Launched In Britain, Shown Encouraging Results Research suggests Wegovy makes users feel they are already full so they eat less. FILE PHOTO: A selection of …